Avalere is committed to the continuous effort for shaping how patients receive care in oncology, during and after COVID-19. In the second episode of our Start Your Day with Avalere podcast series, Avalere's cell and gene therapy experts will discuss how healthcare stakeholders are considering value when paying for durable therapies.